Tesco PLC
7 August 2001
THE NUTRI CENTRE AT TESCO
Tesco has bought a majority stake, 50.1%, for the net sum of £2.93 million, in
The Nutri Centre, the specialist mail order and retail group, it is announced
today.
The move is the first major investment into the Complementary Medicine market
by a global retailer.
The Nutri Centre founder and current owner, Rohit Mehta, becomes the Tesco
Healthy Living Consultant, and will continue managing the business following
the deal signed today.
The Complementary Medicine market, predicted to be worth over £300 million in
the UK by 2003, is expected to grow at some 15% per annum as alternative
therapies and treatments become more mainstream amongst British customers and
health practitioners. The market has more than doubled in the last five years.
A range of 85 Nutri Centre@Tesco products will be available initially in 50
Tesco stores from 7th August; a roll-out plan to over 200 stores is being
finalised. The full range of over 22,000 products will be available through a
new mail order catalogue alongside information leaflets in the stores.
Customers will be able to make orders by telephone for home delivery.
Additional plans are underway to offer access through the Tesco.com web-site.
Tesco believe the UK Complementary medicine market is set to expand. British
consumers still spend significantly less than their American and European
counterparts on alternative therapies and treatments.
Said Tim Mason, Tesco Marketing Director, 'Customers tell us they want to live
a healthier lifestyle so demand for natural products is booming. Our link with
the Nutri Centre will give customers access to an exciting range of
complementary medicine - catering for all their needs and opening up a whole
new market to Tesco.'
Rohit Mehta said 'Our link to Tesco will bring natural products to the mass
market. Customers will now have the experience of the Nutri Centre@Tesco in
their local store.'
- ends -
Contact: Tesco Press Office 01992 644645 / 646869
Out of hours 01992 637271
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.